cw_20130221112645.jpg

This collaboration will lead to a wide range of E-communicative Devices and Packagings.

The first products as a result of this cooperation between Qolpac and BeyonDevices, with OtCM inside, will be an innovative Dry Powder Inhaler for efficient pulmonary drug delivery and the OtCM Cap for the standard Rexam Pillboxes widely used in the USA.

BeyonDevices focuses on the development of innovative medical devices and medical technology while improving patient compliance through smart packaging, with the purpose of exploring niche markets in the Pharmaceutical Primary Packaging as well as Medical Technology & Device Industries.

BeyonDevices brings to the market leading innovative solutions for drug delivery, having recently introduced in the women’s health market segment its patented and radically innovative vaginal applicator and has developed in the area of pulmonary drug delivery a novel DPI system, which presents a significant element of in-house innovation in the powder dispersion technology, as well as focusing from the onset on improved consumer convenience and safety and presenting to manufacturers an off-the-shelf economic alternative to current market leading product.

Today BeyonDevices already supports companies in Europe and elsewhere which develop packaging products and devices for the Health Industry and is the partner of choice for companies looking to stay at the forefront of the market.

Qolpac focus aims on quality of life of the individual patient, by supplying a state-of-the-art smart phone-application, which is able to communicate with (Qolpac’s OtCM™) smart packaged medications.

We aim to stimulate and encourage the patient to improve the quality of life by linking all medical information to his/her buddy, therapist or project leader. This can create situations where the patient gets the reminder from his father, daughter, doctor or therapist based on the free will of the patient. Qolpac will also deliver information services, including information about therapy adherence and diagnostic measuring results, creating a mirror for the patient where he can see the results of the actions he made. Objective Therapy Compliance Measurement Technology allows you to register the moment that the user has taken his medication from its package. This information can be read out real-time by a Smartphone or, at a later stage, by an event-taker.

The first products as a result of the cooperation between Qolpac and BeyonDevices, with OtCM inside, will be a innovative capsule based Dry Powder Inhaler for efficient pulmonary drug delivery and the OtCM Cap for the standard Rexam Pillboxes widely used in the USA.

For further Information
BeyonDevices: filipeserafim@beyondevices.eu
Qolpac: info@qolpac.com